ArticlePloS one2025
Analysis of government subsidy strategies in the supply chain of science and technology innovation platform.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the current era of technological advancements and intense global competition, innovation in Science and Technology (S&T) has become a crucial aspect of every country's development strategy, and the development of cutting-edge technologies in core areas is of utmost importance. Innovation platforms that offer services for core technologies can be classified into three operational models: Public Welfare Platforms, Social Enterprise Platforms, and Commercial Platforms, depending on their objectives. To accelerate the realization of S&T innovation, the government provides subsidies to guide the S&T innovation platform and increase the participation of innovation subjects. With the help of optimization theory and supply chain theory, this paper constructed a model employing the game approach to delve into the pricing strategies of S&T platforms under three distinct models: Public Welfare Platform, Social Enterprise Platform, and Commercial Platform. The paper also discusses the effects of government subsidies on different innovation subjects. The study demonstrates that all three operational models can achieve the optimal membership fee for research users and the optimal commission rebate paid by the platform to resource providers. In the context of the Public Welfare Platform, despite the highest social welfare, the platform's profit remains negative. Consequently, price subsidies are required for research users. At this juncture, the government subsidies to the S&T innovation platform yield the greatest social welfare yet the lowest profit for the platform. In contrast, the Social Enterprise Platform entails government subsidies for resource providers and research users, which can enhance the platform's profit. The effect of subsidizing the resource providers on the profit growth of the S&T innovation platform is more significant than the effect on the improvement of social welfare. In the context of the Commercial Platform, regardless of the existence of government subsidies, the growth of social welfare and platform profits with the platform service level can be achieved. Furthermore, government subsidies for scientific research users are the most effective. These results provide theoretical and practical lessons for the pricing of the S&T innovation platform and the subject of government subsidies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.